Talon Biomarkers is a contract research organization that specializes in high-parameter biomarker assay development and qualification. The company designs studies, runs assays, and interprets complex immune-profiling data to help life sciences organizations generate translational evidence. Its proprietary Flight Path tool allows users to explore disease-specific biomarkers across genetic, plasma, cellular, and tissue data.
Funding
Funding not disclosed
Founders
Product
Problem
Life sciences researchers face a fragmented vendor ecosystem where incompatible measurement frameworks across immune-profiling platforms make multi-platform data difficult to trust. Researchers are often left with raw data and limited guidance, expected to piece together meaningful conclusions from increasingly complex studies without integrated support.
Solution
Talon Biomarkers is a contract research organization that specializes in high-parameter analysis, designing studies, running assays, and interpreting data to turn valuable samples into scientific evidence. The company works ahead of the assay by collaborating with technology developers, testing platforms before they reach the market, and turning emerging capability into methods studies can rely on. Talon combines scientific expertise, analytical capabilities, and purpose-built infrastructure to bridge the gap between complex data generation and actionable insights. The company's proprietary Flight Path tool allows users to search any disease to explore its genetic, plasma/serum, cell type, and tissue biomarkers, graded by evidence.
Target Audience
Primary customers are pharmaceutical and biotechnology companies, clinical research organizations, and academic researchers conducting immunotherapy, oncology, and immune-monitoring studies who need reliable biomarker data for drug development decisions.
Features
- Proprietary Flight Path biomarker discovery tool that searches diseases across genetic, plasma/serum, cell type, and tissue biomarker categories with evidence grading
- High-parameter flow cytometry capabilities including 27-color panel development and in-house spectral optimization to resolve interference issues
- Dye Simplicity Score that quantifies spectral overlap across a panel's dyes without bench testing
- GCLP-compliant laboratory operations combining multi-omic cytometry and computational tools
- Study design, assay execution, and data interpretation services under one roof
- Technology partnership program that tests emerging platforms before they reach the market